these results suggest that n-pomc , despite the fact that it can not be used to discriminate lung cancer patients from controls , is a biomarker which may predict relapse in patients successfully treated by chemotherapy for their pulmonary neoplasm .
C0024109
lung
C0024121
pulmonary neoplasm